// App-Quantinova.ai

: Disagregin: A Possible New αIIbβ3 Integrin Inhibitor to Prevent Arterial Thrombosis

Researchers

Presenter

  • D.L. van den Kerkhof

Principal Investigators

  • M. Nagy

  • J.H. Ippel

  • J.W.M. Heemskerk

  • T.M. Hackeng

  • I. Dijkgraaf

Medical Centers

  • Maastricht University, Cardiovascular Research Institute, Maastricht, the Netherlands

  • , Department of Biochemistry, Maastricht, the Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • eptifibatide

  • disagregin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved